This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: Michael Centola: Innovator in Genetic Research
Introduction
Michael Centola is a notable inventor based in Takoma Park, MD (US). He has made significant contributions to the field of genetic research, particularly in relation to familial Mediterranean fever (FMF). His work has implications for understanding and diagnosing this genetic condition.
Latest Patents
Michael Centola holds a patent for the invention titled "Pyrin gene and mutants thereof, which cause familial Mediterranean fever." This invention provides the nucleic acid sequence encoding the protein associated with FMF, designated as MEFV. The patent encompasses fragments of the DNA sequence, the corresponding RNA transcript, and the amino acid sequence for the pyrin protein. Notably, it also details mutants of the nucleic acid and amino acid sequences associated with FMF, including three missense mutations: M6801, M694V, K695R, and V726A. Additionally, the invention includes methods for diagnosing patients at risk for FMF and the associated kits.
Career Highlights
Throughout his career, Michael Centola has focused on genetic research and the implications of his findings for medical science. His patent reflects a deep understanding of the genetic underpinnings of familial Mediterranean fever and showcases his innovative approach to solving complex biological problems.
Collaborations
Michael has collaborated with notable colleagues, including P Paul Liu and Trevor Blake. Their combined expertise has likely contributed to the advancements in research and the successful development of his patent.
Conclusion
Michael Centola's work in genetic research, particularly regarding familial Mediterranean fever, highlights his innovative contributions to the field. His patent serves as a valuable resource for diagnosing and understanding this genetic condition.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile